Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor-specific gene delivery using genetically engineered bacteria.

J Theys1, S Barbé, W Landuyt

  • 1MAASTRO lab, Maastricht Radiation Oncology, Maastricht, The Netherlands. jan.theys@maastro.unimaas.nl

Current Gene Therapy
|May 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revisiting cholesterol metabolism in hepatocellular carcinoma: a hidden driver of systemic therapy response.

ESMO gastrointestinal oncology·2026
Same author

HIV-Gag VLP-based vaccine purification at manufacturing scale: Combination of counterflow centrifugation and nuclease treatment as a key to DNA depletion.

New biotechnology·2026
Same author

Recurrence detection in head and neck cancer: a systematic review of routine follow-up practices and clinical implications.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

Optimizing nuclease treatment to enhance anion exchange chromatography of HIV-derived virus-like particles.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2025
Same author

Atmospheric-river-induced foehn events drain glaciers on Novaya Zemlya.

Nature communications·2024
Same author

Intratumor genetic heterogeneity and head and neck cancer relapse.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2024

Non-pathogenic bacteria offer a novel gene delivery system for cancer therapy. These bacteria selectively target tumors, leveraging the tumor micro-environment for anti-tumor effects, complementing conventional treatments.

Area of Science:

  • Oncology
  • Microbiology
  • Biotechnology

Background:

  • Loco-regional cancer control is crucial for treatment outcomes.
  • Conventional radiotherapy and chemotherapy face limitations.
  • Cancer's genetic basis drives gene therapy development.

Purpose of the Study:

  • To review bacterial gene delivery systems as an alternative cancer treatment.
  • To explore the potential of non-pathogenic bacteria for tumor targeting and lysis.
  • To discuss the advantages and challenges of this approach.

Main Methods:

  • Review of existing literature on bacterial anti-cancer applications.
  • Focus on anaerobic bacteria like Clostridium and attenuated Salmonella.
  • Discussion of tumor micro-environment properties, including hypoxia.

Related Experiment Videos

Main Results:

  • Historical reports of tumor regression in bacterially infected patients.
  • Demonstration of bacterial localization and lysis in experimental tumors.
  • Identification of attenuated Salmonella as promising for selective amplification and therapeutic protein expression.

Conclusions:

  • Bacterial gene delivery is a promising alternative/complementary cancer treatment.
  • Tumor hypoxia is a key factor enabling bacterial targeting.
  • Combined modalities, including radiation-inducible promoters and vascular targeting, enhance efficacy.